Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute upper GI bleeding management

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Treat haematemesis, melaena with shock, syncope or ongoing brisk bleeding as a time-critical emergency. Use an ABCDE approach, call senior emergency, gastroenterology, anaesthetic and transfusion support, obtain large-bore venous access and activate the local major-haemorrhage protocol when indicated. Protect the airway when consciousness, continuing haematemesis or aspiration risk makes endoscopy unsafe. Resuscitation precedes endoscopy, but uncontrolled bleeding requires simultaneous organisation of urgent haemostasis.

Synopsis

Resuscitate acute upper gastrointestinal haemorrhage before diagnosis, risk-stratify consistently, initiate cause-specific pre-endoscopy treatment, deliver timely therapeutic endoscopy, and coordinate rebleeding, antithrombotic and secondary-prevention decisions.

  • Upper-GI bleeding can present with haematemesis, coffee-ground vomit, melaena or brisk haematochezia; haemodynamic state matters more than the apparent colour or volume.
  • Calculate the Glasgow–Blatchford score at first assessment and the full Rockall score after endoscopy; a score is an adjunct and never overrides shock or active bleeding.
  • Use a restrictive red-cell transfusion strategy in most haemodynamically stable patients, commonly considering transfusion below 70 g/L, while individualising for exsanguination and cardiovascular disease.
  • NICE recommends immediate endoscopy after resuscitation for unstable severe bleeding and endoscopy within 24 hours for other admitted patients with upper-GI haemorrhage.
  • Do not routinely give acid suppression before diagnostic endoscopy for suspected non-variceal bleeding under NICE guidance; give PPI after endoscopic evidence of recent haemorrhage.
  • If variceal bleeding is suspected, start terlipressin and prophylactic antibiotic treatment at presentation unless contraindicated, then arrange urgent variceal haemostasis.
  • For non-variceal haemostasis, adrenaline injection must not be used alone; combine an accepted mechanical or thermal method according to lesion and expertise.
  • Rebleeding after initial endoscopic control needs prompt senior reassessment, repeat endoscopic therapy where appropriate and early interventional-radiology or surgical escalation if control fails.

Key red flags

Occult shock

Cool peripheries, delayed capillary refill, confusion, oliguria, postural symptoms or rising lactate may precede hypotension. Older people and those taking rate-limiting medicines may not become tachycardic.

Variceal probability

Known cirrhosis, portal hypertension, splenomegaly, ascites, thrombocytopenia or previous varices raises suspicion and should trigger pre-endoscopy vasoactive and antibiotic therapy while other sources remain possible.

Airway danger

Ongoing large-volume haematemesis, agitation, encephalopathy or reduced consciousness makes aspiration likely. Secure experienced anaesthetic assessment before sedated endoscopy rather than relying on suction alone.

Investigation priorities

01
Serial observations and perfusion assessmentFirst step

Measure current physiological threat and response to resuscitation.

Management branches

ResuscitateRestore perfusion safely

Any patient presents with suspected acute upper-GI bleeding and physiological or ongoing blood-loss concern.

  1. Use ABCDE, monitor continuously when unstable, insert appropriate venous access, send urgent bloods and crossmatch, and summon senior endoscopy, anaesthetic and transfusion support early.
  2. Give crystalloid and blood components according to response and the local haemorrhage protocol, using restrictive red-cell thresholds only when the patient is sufficiently stable for concentration-based decisions.
  3. Review antithrombotics and comorbidity, calculate Glasgow–Blatchford score, and document escalation, airway and ceiling-of-care decisions while definitive haemostasis is organised.

Key medicines

Terlipressin for suspected variceal bleedingUsing Glypressin 1 mg, administer 2 mg by intravenous injection every 4 hours initially. After the first dose, use 1 mg every 4 hours if body weight is below 50 kg or adverse effects occur. Treat until bleeding has remained controlled for 24 hours, capped at 48 hours by the current SmPC. NICE says to stop terlipressin after definitive haemostasis or within 5 days, but that pathway ceiling does not override a named product's shorter licensed maximum.Review coronary, peripheral or mesenteric ischaemia, arrhythmia, severe hypertension, pregnancy context, sodium and fluid balance. Stop and seek senior advice for chest pain, ischaemic signs, severe hyponatraemia or ineffective control.
Prophylactic antibiotic for suspected variceal haemorrhageStart promptly using the local cirrhosis and antimicrobial guideline, with agent, route and duration selected for allergy, renal function, prior colonisation and regional resistance.Obtain cultures when infection is suspected without delaying treatment, review for Clostridioides difficile and resistant-organism risk, and stop or narrow at the protocol endpoint.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG141: Acute upper gastrointestinal bleedingNational resuscitation, risk scoring, transfusion, endoscopy, haemostasis, PPI and variceal-treatment recommendations.
  • BSG acute upper-GI bleed care bundleUK multi-society first-24-hour standards covering recognition, resuscitation, risk, treatment, referral and review.
  • BSG variceal haemorrhage guidelineUK specialist guidance for acute variceal control and secondary prevention, retained for acute practice after BSG review.
  • BSG and ESGE antithrombotic endoscopy guidelineUpdated management of antiplatelets, warfarin and direct oral anticoagulants during acute GI haemorrhage and endoscopy.
  • Glypressin 1 mg summary of product characteristicsNamed-product dose, 48-hour maximum, contraindications and required monitoring for bleeding oesophageal varices.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draft
Clinical stateAwaiting review
JurisdictionUnited Kingdom